Clinical Trial Update: Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety study assessing subcutaneous ibalizumab in healthy volunteers to evaluate tolerability and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ibalizumab (ibalizumab)

Snippet

Sponsor: TaiMed Biologics Inc. | Conditions: Prevention of Infection With HIV-1 | Phase 1 | Status: COMPLETED